Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study
- PMID: 18458146
- PMCID: PMC2494632
- DOI: 10.2337/dc08-0025
Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study
Abstract
Objective: We assessed the lifetime risk of cardiovascular disease (CVD) among individuals with and without obesity and diabetes.
Research design and methods: Participants were drawn from the original and offspring cohorts of the Framingham Heart Study. Lifetime (30-year) risk of CVD was assessed using a modified Kaplan-Meier approach adjusting for the competing risk of death, beginning from age 50 years.
Results: Over 30 years, the lifetime risk of CVD among women with diabetes was 54.8% among normal-weight women and 78.8% among obese women. Among normal-weight men with diabetes, the lifetime risk of CVD was 78.6%, whereas it was 86.9% among obese men.
Conclusions: The lifetime risk of CVD among individuals with diabetes is high, and this relationship is further accentuated with increasing adiposity.
Similar articles
-
Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity.JAMA Cardiol. 2018 Apr 1;3(4):280-287. doi: 10.1001/jamacardio.2018.0022. JAMA Cardiol. 2018. PMID: 29490333 Free PMC article.
-
Lifetime risk and years lived free of total cardiovascular disease.JAMA. 2012 Nov 7;308(17):1795-801. doi: 10.1001/jama.2012.14312. JAMA. 2012. PMID: 23117780 Free PMC article.
-
External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.Med J Aust. 2019 Mar;210(4):161-167. doi: 10.5694/mja2.12061. Epub 2019 Jan 18. Med J Aust. 2019. PMID: 30656697
-
Obesity, diabetes, and risk of cardiovascular disease in the elderly.Am J Geriatr Cardiol. 2002 Mar-Apr;11(2):119-23,125. doi: 10.1111/j.1076-7460.2002.00998.x. Am J Geriatr Cardiol. 2002. PMID: 11872970 Review.
-
Cardiovascular disease risk factors, type 2 diabetes mellitus, and the Framingham Heart Study.Trends Cardiovasc Med. 2010 Apr;20(3):90-5. doi: 10.1016/j.tcm.2010.08.001. Trends Cardiovasc Med. 2010. PMID: 21130952 Free PMC article. Review.
Cited by
-
Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors.Cardiovasc Diabetol. 2010 Aug 30;9:45. doi: 10.1186/1475-2840-9-45. Cardiovasc Diabetol. 2010. PMID: 20804556 Free PMC article. Review.
-
Management of Lipid Abnormalities in Patients with Diabetes.Curr Cardiol Rep. 2019 Nov 22;21(11):147. doi: 10.1007/s11886-019-1246-1. Curr Cardiol Rep. 2019. PMID: 31758270 Free PMC article. Review.
-
The lifetime risk of developing type II diabetes in an urban community in Mumbai: findings from a ten-year retrospective cohort study.BMC Public Health. 2023 Aug 31;23(1):1673. doi: 10.1186/s12889-023-16596-6. BMC Public Health. 2023. PMID: 37653484 Free PMC article.
-
Lipid control in patients with diabetes mellitus.Nat Rev Cardiol. 2011 May;8(5):278-90. doi: 10.1038/nrcardio.2011.23. Epub 2011 Mar 15. Nat Rev Cardiol. 2011. PMID: 21403658 Review.
-
Medical devices and diagnostics for cardiovascular diseases in low-resource settings.J Cardiovasc Transl Res. 2014 Nov;7(8):737-48. doi: 10.1007/s12265-014-9591-3. Epub 2014 Oct 8. J Cardiovasc Transl Res. 2014. PMID: 25294168 Review.
References
-
- Leibson CL, Williamson DF, Melton LJ 3rd, Palumbo PJ, Smith SA, Ransom JE, Schilling PL, Narayan KM: Temporal trends in BMI among adults with diabetes. Diabetes Care 24:1584–1589, 2001 - PubMed
-
- Lloyd-Jones DM, Larson MG, Beiser A, Levy D: Lifetime risk of developing coronary heart disease. Lancet 353:89–92, 1999 - PubMed
-
- Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PW, Wolf PA, Levy D: Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 113:791–798, 2006 - PubMed
-
- Beiser A, D’Agostino RB Sr, Seshadri S, Sullivan LM, Wolf PA: Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study: the Practical Incidence Estimators (PIE) macro. Stat Med 19:1495–1522, 2000 - PubMed
-
- Gaynor JJ, Feuer EJ, Tan CC, Wu DH, Little CR, Straus DJ, Clarkson BD, Brennan MF: On the use of cause-specific failure and conditional failure probabilities—examples from clinical oncology data. J Am Stat Assoc 88:400–409, 1993